com.insightguru.giraffe.server.utils.PresentationUtil$PresentationTitle@92626f
This site requires JavaScript to function properly.
For help enabling JavaScript click here.
Here are some sample widgets you could interact with from this dashboard:
(1) Revenues expected to be slightly ahead of consensus estimates
Trefis estimates ABT's Q2 2021 revenues to be $9.85 Bil, slightly ahead of the consensus estimate of $9.69 Bil
Estimated Revenues - 2021Q2(E)
Trefis Estimates for Abbott Revenues:
Expected Change (YoY): 34.4%
The chart to the right highlights trends in Abbott's Revenues over the last four quarters along with our forecast for Q2 2021.
Quarterly Revenue Trend
(2) EPS likely to marginally beat consensus estimates
ABT's Q2 2021 earnings per share (EPS) expected to be $1.07 per Trefis analysis, marginally beating the consensus estimate of $1.02 by 4.9%
Estimated EPS- 2021Q2(E)
Trefis Estimates for Abbott EPS:
Expected Change (YoY): 256.7%
The chart to the right highlights trends in ABT's EPS over the last four quarters along with our forecast for Q2 2021.
Quarterly EPS Trend
(3) Stock price estimate 11% higher than current market price
Trefis maintains a fair value of $132 for ABT's stock as opposed to the current market price of roughly $119.
ABT Stock Price
The Trefis Price Estimate for Abbott stock represents the fair value for the company's stock over a one-year horizon.
Details about the chances of a rise in ABT stock in the near term can be found in a separate interactive dashboard.
The chart to the right highlights trends in ABT's stock price at the end of each of the last four quarters as well as the current stock price.
Stock Price (Quarter End)
#1. Estimating Abbott's Total Revenues:
Abbott's Revenues have seen a increase of 13.2% from around $31 Bil in FY2018 to $35 Bil in FY2020 and we expect it to increase to $40 Bil in FY2021
Total Revenue
A Separate Interactive Dashboard Analysis On Abbott's Revenues Details How The Company Makes Money.
#2. Deriving Abbott's Adjusted Net Income:
Abbott's Adjusted Net Income has increased from around $5.1 Bil in FY2018 to $6.6 Bil in FY2020 and we expect it to increase to $8.1 Bil in FY2021
This change is likely to be led by higher revenues and improved margins.
A Separate Interactive Dashboard Analysis On Abbott's Margins Highlights The Company's Various Expenses Components In Detail.
Adjusted Net Income [AxB]
Adjusted Net Income Margin [A]
Total Revenue [B]
#3. Determining Abbott's Adjusted EPS:
Abbott's Adjusted EPS has increased from $2.9 in FY2018 to $3.67 in FY2020 and we expect it to increase to $4.55 in FY2021
The change in EPS can be attributed to an increase in adjusted net income and a lower expected share count due to stock repurchases.
Adjusted EPS [A÷B]
Adjusted Net Income [A]
Shares Outstanding [B]
#4. Estimating Abbott's Share Price:
Our Price Estimate of $132 For Abbott's Stock is based on our Detailed Valuation Model, and implies a 29.0x P/E Multiple on expected FY2021 Adjusted EPS of $4.55
Trefis Price Estimate [AxB]
Adjusted EPS [A]
P/E Multiple [B]